AbbVie expects $2.7 billion R&D charge in third quarter, lowers annual profit forecast – Reuters

  1. AbbVie expects $2.7 billion R&D charge in third quarter, lowers annual profit forecast  Reuters
  2. AbbVie to Host Third-Quarter 2025 Earnings Conference Call  Yahoo Finance
  3. AbbVie expects $2.7 billion R&D charge in third quarter By Reuters  Investing.com
  4. AbbVie sees $1.50 per share unfavorable impact in Q3 from milestones expense  TipRanks
  5. AbbVie Says $2.7 Billion in Costs Seen Cutting Q3 EPS by $1.50  MarketScreener

Continue Reading